Cargando…

Old and new antirheumatic drugs for the treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Benucci, Maurizio, Damiani, Arianna, Infantino, Maria, Manfredi, Mariangela, Quartuccio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de rhumatologie. Published by Elsevier Masson SAS. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167223/ https://www.ncbi.nlm.nih.gov/pubmed/32321635 http://dx.doi.org/10.1016/j.jbspin.2020.03.013

Ejemplares similares

Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19()
por: Benucci, Maurizio, et al.
Publicado: (2020)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
por: Benucci, Maurizio, et al.
Publicado: (2019)

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
por: Benucci, Maurizio, et al.
Publicado: (2020)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2018)

Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2022)

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
por: Quartuccio, Luca, et al.
Publicado: (2020)

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease
por: Benucci, Maurizio, et al.
Publicado: (2022)

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci, Maurizio, et al.
Publicado: (2018)

Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174
por: Benucci, Maurizio, et al.
Publicado: (2023)

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
por: Benucci, Maurizio, et al.
Publicado: (2020)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations
por: Benucci, Maurizio, et al.
Publicado: (2021)

Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
por: Benucci, Maurizio, et al.
Publicado: (2020)

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation
por: TUFAN, Abdurrahman, et al.
Publicado: (2021)

New antirheumatic effects of biphosphonate treatment
por: Konenkova, L, et al.
Publicado: (2001)

Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
por: Kawazoe, Mai, et al.
Publicado: (2021)

Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study
por: Treppo, Elena, et al.
Publicado: (2020)

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
por: Infantino, Maria, et al.
Publicado: (2021)

Kinase inhibitors: a new class of antirheumatic drugs
por: Kyttaris, Vasileios C
Publicado: (2012)

Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?
por: Benucci, Maurizio, et al.
Publicado: (2022)

The role of antirheumatics in patients with COVID-19
por: Nissen, Christoffer B, et al.
Publicado: (2021)

COVID-19 vaccination and antirheumatic therapy
por: Arnold, Jack, et al.
Publicado: (2021)

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
por: TUFAN, Abdurrahman, et al.
Publicado: (2020)

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
por: Benucci, Maurizio, et al.
Publicado: (2017)

Treatment of COVID-19: old tricks for new challenges
por: Cunningham, Anne Catherine, et al.
Publicado: (2020)

Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique()
por: Quartuccio, Luca, et al.
Publicado: (2020)

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
por: Pontali, Emanuele, et al.
Publicado: (2023)

Answer to Vieira et al. “Cytokine profile as a prognostic tool in coronavirus disease 2019”. Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006
por: Quartuccio, Luca, et al.
Publicado: (2021)

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015)

Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs
por: Sokka, Tuulikki, et al.
Publicado: (2008)

INADEQUATE IMMUNE RESPONSE TO COVID-19 VACCINES IN THE PRESENCE OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
por: KRISHNAIAH, AISHWARYA, et al.
Publicado: (2022)

Antibody engineering to develop new antirheumatic therapies
por: Isaacs, John D
Publicado: (2009)

Antirheumatic drugs and reproduction in women and men with chronic arthritis
por: Bazzani, Chiara, et al.
Publicado: (2015)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
por: Xia, Yunfei, et al.
Publicado: (2016)

Doxycycline: new tricks for an old drug
por: Barbie, David A., et al.
Publicado: (2015)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7uuj6iu0dd78rftm7if9v9thbe